Logos Global Management LP Shattuck Labs, Inc. Transaction History

Logos Global Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.36 - $21.08 $1.67 Million - $4.22 Million	-200,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.57 - $28.95 $3.51 Million - $5.79 Million	200,000 New	200,000 $4.08 Million
Q1 2021 May 17, 2021	SELL	$27.92 - $52.5 $3.39 Million - $6.38 Million	-121,562 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$19.0 - $57.61 $2.31 Million - $7 Million	121,562 New	121,562 $6.37 Million

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.2M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.